New report published by Global Info Research which offers insights on the global Enzyme Replacement Therapy market.
Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-enzyme-replacement-therapy-market_p91159.html
Global Enzyme Replacement Therapy Market: Forecast by Type / Application / Region
The major players in global Enzyme Replacement Therapy market include: Sanofi, Shire, BioMarin, AbbVie , Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care and Leadiant Biosciences.
On the basis of product, the Enzyme Replacement Therapy market is primarily split into: Injectable Agents, Oral Agents.
On the basis on the end users/applications covers: Gaucher Disease, Fabry Disease, MPS Disease, Gastrointestinal Disease and Others.
The classification of enzyme replacement therapy includes injectable agents and oral agents, and the revenue proportion of injectable agents in 2017 is about 62.38%, and the proportion is in increasing trend from 2013 to 2017.
In the last several years, global market of enzyme replacement therapy developed rapidly, with an average growth rate of 13.55%. In 2017, global revenue of enzyme replacement therapy is nearly 7.39 billion USD.
Enzyme replacement therapy is widely used in gaucher disease, fabry disease, mps disease, gastrointestinal diseases and other field. The most proportion of enzyme replacement therapy is for MPS Disease, and the revenue in 2017 is 1.73 billion USD.
North America is the largest consumption place, with a consumption market share nearly 70.77% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 21.25%.
Market competition is intense. Sanofi, Shire, BioMarin, AbbVie , etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-enzyme-replacement-therapy-market_p91159.html
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Related Information:
United States Enzyme Replacement Therapy Market 2018 Forecast to 2023
Europe Enzyme Replacement Therapy Market 2018 Forecast to 2023
North America Enzyme Replacement Therapy Market 2018 Forecast to 2023
Asia-Pacific Enzyme Replacement Therapy Market 2018 Forecast to 2023
China Enzyme Replacement Therapy Market 2018 Forecast to 2023
EMEA Enzyme Replacement Therapy Market 2018 Forecast to 2023
Global Enzyme Replacement Therapy Market 2018 Forecast to 2023
Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com
Your information will never be shared with any third party.